Publications by authors named "P B Storm"

Article Synopsis
  • Pediatric low-grade gliomas (pLGGs) show varying treatment responses and poor outcomes when complete tumor removal isn't possible, making early treatment prediction important.
  • A radiogenomic analysis combining MRI and RNA sequencing reveals three immune clusters in pLGGs, with one cluster having higher immune activity but worse prognosis, suggesting they might benefit from immunotherapy.
  • A developed radiomic signature accurately predicts these immune profiles and progression-free survival, identifying high-risk patients for potential targeted therapies.
View Article and Find Full Text PDF

Background: Fully automatic skull-stripping and tumor segmentation are crucial for monitoring pediatric brain tumors (PBT). Current methods, however, often lack generalizability, particularly for rare tumors in the sellar/suprasellar regions and when applied to real-world clinical data in limited data scenarios. To address these challenges, we propose AI-driven techniques for skull-stripping and tumor segmentation.

View Article and Find Full Text PDF

Dopaminergic (DA) neurons exhibit significant diversity characterized by differences in morphology, anatomical location, axonal projection pattern, and selective vulnerability to disease. More recently, scRNAseq has been used to map DA neuron diversity at the level of gene expression. These studies have revealed a higher than expected molecular diversity in both mouse and human DA neurons.

View Article and Find Full Text PDF

Background And Purpose: Privacy concerns, such as identifiable facial features within brain scans, have hindered the availability of pediatric neuroimaging datasets for research. Consequently, pediatric neuroscience research lags adult counterparts, particularly in rare disease and under-represented populations. The removal of face regions (image defacing) can mitigate this, however existing defacing tools often fail with pediatric cases and diverse image types, leaving a critical gap in data accessibility.

View Article and Find Full Text PDF
Article Synopsis
  • Stem cell therapies for Parkinson's disease are progressing, with new clinical trials starting to test human pluripotent stem cells for creating transplantable dopamine-producing cells.
  • These dopamine progenitor cells initially appear uniform but develop into a mix of different cell types after being transplanted into patients.
  • Research using advanced techniques like RNA-seq has revealed that key components of these grafts, including dopamine neurons and astrocytes, originate from a single type of precursor cell that can become multiple cell types.
View Article and Find Full Text PDF